Apotea AB (publ) (STO:APOTEA)
Sweden · Delayed Price · Currency is SEK 113.28
-1.24 (-1.08%)
At close: Aug 1, 2025
Chimerix Market Cap
Apotea AB has a market cap or net worth of 11.79 billion as of August 1, 2025.
Market Cap
11.79B
Enterprise Value
12.07B
Revenue
6.94B
Ranking
n/a
PE Ratio
47.14
Stock Price
$113.28
Market Cap Chart
Since December 6, 2024, Apotea AB's market cap has increased from 8.63B to 11.79B, an increase of 36.60%. That is a compound annual growth rate of 61.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 11.92B | 36.25% |
| Dec 30, 2024 | 8.75B | 1.35% |
| Dec 6, 2024 | 8.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 91.11B |
| Sectra AB | 69.94B |
| Getinge AB | 51.61B |
| Camurus AB | 40.70B |
| Medicover AB | 40.61B |
| Asker Healthcare Group AB | 38.41B |
| Bonesupport Holding AB | 21.77B |
| AddLife AB | 21.07B |